Bill Title: To amend title XVIII of the Social Security Act to extend eligibility for certain payment increases for biosimilar biological products under the Medicare program.

Sponsorship: Partisan Bill (Democrat 1)

Status: (Introduced - Dead) 2023-11-17 - Referred to the Subcommittee on Health. [HB6400 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Introduced	2023-12-04	PDF	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for US Congress HB6400

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for US Congress HB6400 currently on file.